EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Large-scale multicenter study reveals anticitrullinated SR-A peptide antibody as a biomarker and exacerbator for rheumatoid arthritis

Yang Xie iD, Chaonan Wei iD, Dongdong Fu iD, Wei Zhang iD, Yan Du, Chuncui Huang iD, Shuyan Liu iD, Ranran Yao iD, Zihao He, Shenghua Zhang, Xu Jin, Bin Shen iD und 22 weitere

Science Advances · 03.01.2025 · 11 (1)

DOI: 10.1126/sciadv.adr8078 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Science Advances, erschienen am 03.01.2025. Verfasst von Yang Xie und 33 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, Peking University People's Hospital & Beijing Key Laboratory for Rheumatism Mechanism and Immune Diagnosis…. Hauptthemen laut MEDLINE: Anti-Citrullinated Protein Antibodies, Arthritis, Rheumatoid, Autoantibodies, Biomarkers. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Current diagnosis and treatment of rheumatoid arthritis (RA) is still challenging. More than one-third of patients with RA could not be accurately diagnosed because of lacking biomarkers. Our recent study reported that scavenger receptor-A (SR-A) is a biomarker for RA, especially for anticyclic citrullinated peptide antibody (anti-CCP)–negative RA. Here, we further identified the B cell autoantigenic epitopes of SR-A. By a large-scale multicenter study including one training and three validation cohorts of 1954 participants, we showed that anticitrullinated SR-A peptide antibody (anti-CSP) was exclusively elevated in RA as a biomarker, particularly useful for seronegative RA. Combination of anti-CSP with anti-CCP demonstrated superior diagnostic value for RA, with sensitivity of 84.83% and specificity of 92.43%. Moreover, RA anti-CSP revealed distinct glycosylation patterns, capable of provoking inflammation in cartilage organoids and exacerbating disease progression in experimental arthritis. Together, these data identify anti-CSP as an RA autoantibody clinically applicable and actively involved in disease pathogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Citrullinated Protein AntibodiesArthritis, RheumatoidAutoantibodiesBiomarkersAdultAgedFemaleHumansMaleMiddle AgedAutoantigensGlycosylationPeptides, CyclicDisease Progression

Substanzen

Anti-Citrullinated Protein AntibodiesAutoantibodiesAutoantigensBiomarkersPeptides, Cyclic

Autor:innen und Institutionen

  • Department of Rheumatology and Immunology, Peking University People's Hospital & Beijing Key Laboratory for Rheumatism Mechanism and Immune Diagnosis (BZ0135), Beijing, China.
  • Department of Rheumatology and Immunology, Xinxiang Central Hospital, Xinxiang, China.
  • Department of Rheumatology and Immunology, First Hospital Affiliated to Baotou Medical College & Inner Mongolia Key Laboratory of Autoimmunity, Baotou, China.
  • Department of Rheumatology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Key Laboratory of Epigenetic Regulation and Intervention, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
  • Arthritis Clinical and Research Center, Peking University People's Hospital, Beijing, China.

ORCID-Profile: Yang Xie, Chaonan Wei, Dongdong Fu, Wei Zhang, Chuncui Huang, Shuyan Liu, Ranran Yao, Bin Shen, Lulu Cao, Ping Wang, Huaqun Zhu, Jing He, Yin Su, Dan Xing, Zhanguo Li, Fanlei Hu

Zitieren

APA

Xie, Y., Wei, C., Fu, D., Zhang, W., Du, Y., Huang, C., Liu, S., Yao, R., He, Z., Zhang, S., Jin, X., Shen, B., Cao, L., Wang, P., Fang, X., Zheng, X., Lin, H., Wei, X., Lin, W., …, & Hu, F. (2025). Large-scale multicenter study reveals anticitrullinated SR-A peptide antibody as a biomarker and exacerbator for rheumatoid arthritis. Science Advances, 11(1). https://doi.org/10.1126/sciadv.adr8078

Vancouver

Xie Y, Wei C, Fu D, Zhang W, Du Y, Huang C, et al. Large-scale multicenter study reveals anticitrullinated SR-A peptide antibody as a biomarker and exacerbator for rheumatoid arthritis. Science Advances. 2025;11(1). doi:10.1126/sciadv.adr8078

BibTeX
@article{Xie2025,
  author = {Xie, Yang and Wei, Chaonan and Fu, Dongdong and Zhang, Wei and Du, Yan and Huang, Chuncui and Liu, Shuyan and Yao, Ranran and He, Zihao and Zhang, Shenghua and Jin, Xu and Shen, Bin and Cao, Lulu and Wang, Ping and Fang, Xiangyu and Zheng, Xi and Lin, Hongying and Wei, Xihua and Lin, Wenhao and Bai, Mingxin and Zhu, Danxue and Li, Yingni and Ding, Yamin and Zhu, Huaqun and Ye, Hua and He, Jing and Su, Yin and Jia, Yuan and Wu, Huaxiang and Wang, Yongfu and Xing, Dan and Qiu, Xiaoyan and Li, Zhanguo and Hu, Fanlei},
  title = {Large-scale multicenter study reveals anticitrullinated SR-A peptide antibody as a biomarker and exacerbator for rheumatoid arthritis},
  journal = {Science Advances},
  year = {2025},
  volume = {11},
  number = {1},
  doi = {10.1126/sciadv.adr8078}
}
Kostenlos starten →